MedPath

Deborah Gentile

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Phase 4:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
3 (100.0%)

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: Usual care (albuterol with or without oral steroid)
First Posted Date
2005-09-19
Last Posted Date
2021-02-01
Lead Sponsor
Deborah Gentile
Target Recruit Count
61
Registration Number
NCT00189436
Locations
🇺🇸

Bellevue Pediatric Associates, Bellevue, Pennsylvania, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

Phase 4
Completed
Conditions
Upper Respiratory Infection
Interventions
Drug: Placebo
First Posted Date
2005-09-19
Last Posted Date
2020-11-18
Lead Sponsor
Deborah Gentile
Target Recruit Count
84
Registration Number
NCT00189475
Locations
🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children

Phase 4
Completed
Conditions
Otitis Media
Ear Infection
Acute Otitis Media
Interventions
Drug: Placebo
First Posted Date
2005-09-19
Last Posted Date
2020-11-18
Lead Sponsor
Deborah Gentile
Target Recruit Count
99
Registration Number
NCT00189462
Locations
🇺🇸

Bellevue Pediatric Associates, Bellevue, Pennsylvania, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath